News for hackers. Stuff that matters.
Re:Goldman Sachs questions whether curing patients is a sust... by mft_ on Friday April 13, 2018 @05:26AM (#16828299)
Drug development is really hard - the odds are stacked against you.

Any successful drug with half a business case will be launched - no company can afford to be picky about cure vs. chronic treatment - there just aren't that many successful drug discoveries to enable it.

There are no comments on this comment yet.